Evolution of platelet and plasma serotonin levels following electroconvulsive therapy in patients with major depressive episode

Author： Quintin P.   Spreux-Varoquaux O.   Kollenbach K.   Gregoire A.   Advenier C.   Chevalier J.F.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 268-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy

By Nahshoni E.   Manor N.   Bar F.   Stryjer R.   Zalsman G.   Weizman A.  

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 121-125

Elsevier

Access to resources Recommend Favorite

Mirtazapine therapy improves sleep disturbances in patients with major depressive disorder

By  

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Assessment of the evolution of anxiety during a treatment of major depressive disorders in ambulatory patients in general practice with fluoxetine (Prozac) 20 mg

By Mesters P.   Martens S.   Taymans J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 290-291

Elsevier

Access to resources Recommend Favorite

Probiotics as an Adjuvant Therapy in Major Depressive Disorder

By  

Current Neuropharmacology, Vol. 14, Iss. 8, 2016-11 ,pp. : 952-958

Bentham Science Publishers

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H.   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite